Herpes zoster incidence in Germany - an indirect validation study for self-reported disease data from pretest studies of the population-based German National Cohort.
German National Cohort
Herpes zoster
Incidence
Postherpetic neuralgia
Self-reports
Validity
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
30 Jan 2019
30 Jan 2019
Historique:
received:
23
08
2017
accepted:
08
01
2019
entrez:
1
2
2019
pubmed:
1
2
2019
medline:
2
3
2019
Statut:
epublish
Résumé
Until now, herpes zoster (HZ)-related disease burden in Germany has been estimated based on health insurance data and clinical findings. However, the validity of self-reported HZ is unclear. This study investigated the validity of self-reported herpes zoster (HZ) and its complication postherpetic neuralgia (PHN) using data from the pretest studies of the German National Cohort (GNC) in comparison with estimates based on health insurance data. Data of 4751 participants aged between 20 and 69 years from two pretest studies of the GNC carried out in 2011 and 2012 were used. Based on self-reports of physician-diagnosed HZ and PHN, age- and sex-specific HZ incidence rates and PHN proportions were estimated. For comparison, estimates based on statutory health insurance data from the German population were considered. Eleven percent (95%-CI, 10.4 to 12.3, n = 539) of the participants reported at least one HZ episode in their lifetime. Our estimated age-specific HZ incidence rates were lower than previous estimates based on statutory health insurance data. The PHN proportion in participants older than 50 years was 5.9% (1.9 to 13.9%), which was in line with estimates based on health insurance data. As age- and sex-specific patterns were comparable with that in health insurance data, self-reported diagnosis of HZ seems to be a valid instrument for overall disease trends. Possible reasons for observed differences in incidence rates are recall bias in self-reported data or overestimation in health insurance data.
Sections du résumé
BACKGROUND
BACKGROUND
Until now, herpes zoster (HZ)-related disease burden in Germany has been estimated based on health insurance data and clinical findings. However, the validity of self-reported HZ is unclear. This study investigated the validity of self-reported herpes zoster (HZ) and its complication postherpetic neuralgia (PHN) using data from the pretest studies of the German National Cohort (GNC) in comparison with estimates based on health insurance data.
METHODS
METHODS
Data of 4751 participants aged between 20 and 69 years from two pretest studies of the GNC carried out in 2011 and 2012 were used. Based on self-reports of physician-diagnosed HZ and PHN, age- and sex-specific HZ incidence rates and PHN proportions were estimated. For comparison, estimates based on statutory health insurance data from the German population were considered.
RESULTS
RESULTS
Eleven percent (95%-CI, 10.4 to 12.3, n = 539) of the participants reported at least one HZ episode in their lifetime. Our estimated age-specific HZ incidence rates were lower than previous estimates based on statutory health insurance data. The PHN proportion in participants older than 50 years was 5.9% (1.9 to 13.9%), which was in line with estimates based on health insurance data.
CONCLUSION
CONCLUSIONS
As age- and sex-specific patterns were comparable with that in health insurance data, self-reported diagnosis of HZ seems to be a valid instrument for overall disease trends. Possible reasons for observed differences in incidence rates are recall bias in self-reported data or overestimation in health insurance data.
Identifiants
pubmed: 30700258
doi: 10.1186/s12879-019-3691-2
pii: 10.1186/s12879-019-3691-2
pmc: PMC6354372
doi:
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
99Références
Intervirology. 1998;41(6):272-7
pubmed: 10325537
Am J Prev Med. 2000 Apr;18(3):215-8
pubmed: 10722987
Stroke. 2000 Jul;31(7):1602-7
pubmed: 10884460
Clin Infect Dis. 2000 Aug;31(2):578-85
pubmed: 10987724
J Clin Epidemiol. 2003 Feb;56(2):148-54
pubmed: 12654409
Proc R Soc Med. 1965 Jan;58:9-20
pubmed: 14267505
Eur J Epidemiol. 2004;19(5):411-6
pubmed: 15233312
J Clin Epidemiol. 2004 Oct;57(10):1096-103
pubmed: 15528061
Eur J Public Health. 2007 Apr;17(2):199-205
pubmed: 16887835
Z Gesundh Wiss. 2010 Aug;18(4):367-374
pubmed: 21124645
Mayo Clin Proc. 2011 Feb;86(2):88-93
pubmed: 21220354
BMC Med Res Methodol. 2011 May 18;11:72
pubmed: 21592352
MMW Fortschr Med. 2010 Jan 14;151 Suppl 4:193-7
pubmed: 21595148
BMC Infect Dis. 2011 Jun 16;11:173
pubmed: 21679419
J Epidemiol Community Health. 2013 Jan;67(1):71-5
pubmed: 22577182
Eur J Health Econ. 2013 Dec;14(6):1015-26
pubmed: 23271349
PLoS One. 2013 Jun 21;8(6):e66485
pubmed: 23805224
Int J Public Health. 2014 Jun;59(3):555-63
pubmed: 24390621
Glob J Health Sci. 2013 Nov 10;6(2):1-11
pubmed: 24576360
Eur J Epidemiol. 2014 May;29(5):371-82
pubmed: 24840228
BMJ Open. 2014 Jun 10;4(6):e004833
pubmed: 24916088
J Clin Epidemiol. 2015 Apr;68(4):452-9
pubmed: 25459981
BMC Infect Dis. 2016 Oct 20;16(1):589
pubmed: 27765026
Am J Public Health. 1989 Nov;79(11):1554-6
pubmed: 2817172
Stroke. 1995 Aug;26(8):1334-7
pubmed: 7631332
Am J Epidemiol. 1994 Apr 15;139(8):813-8
pubmed: 8178794
J Clin Epidemiol. 1996 Dec;49(12):1407-17
pubmed: 8970491
Am J Epidemiol. 1997 Apr 15;145(8):762-9
pubmed: 9126003
Popul Trends. 1997 Spring;(87):36-40
pubmed: 9134574
Am J Epidemiol. 1998 May 15;147(10):969-77
pubmed: 9596475
Infection. 1998 Nov-Dec;26(6):359-63
pubmed: 9861560